| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/18/2002 | CA2433687A1 Soluble cyclic analogues of beta amyloid peptide |
| 07/18/2002 | CA2433652A1 Active metabolite of antifungal compound |
| 07/18/2002 | CA2433449A1 Metabolic gene polynucleotides and polypeptides and uses thereof |
| 07/18/2002 | CA2432883A1 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 07/18/2002 | CA2432350A1 Method for inhibiting the expression of a target gene |
| 07/18/2002 | CA2430588A1 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |
| 07/18/2002 | CA2429956A1 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
| 07/18/2002 | CA2428497A1 Targeted modification of intracellular compounds |
| 07/18/2002 | CA2427840A1 Methods of using imxp-888 and imxp-888 antagonists |
| 07/18/2002 | CA2426588A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 07/17/2002 | EP1223214A1 Gene encoding novel human secretory phospholipase a 2? |
| 07/17/2002 | EP1222933A1 Generation and/or reduction of new lung tissue in an affected lung, by modulation of the Wnt-pathway |
| 07/17/2002 | EP1222931A1 Percutaneous absorption promoters for electroporation |
| 07/17/2002 | EP1222919A2 Compositions comprising glycoprotein matrix and active compound and methods for manufacture thereof |
| 07/17/2002 | EP1222918A1 Microcapsules for stabilizing cosmetic, pharmaceutical or food products |
| 07/17/2002 | EP1222913A1 Depilatories and agents for external use |
| 07/17/2002 | EP1222683A1 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 07/17/2002 | EP1222465A1 Method for monitoring treatment with a parathyroid hormone |
| 07/17/2002 | EP1222459A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 07/17/2002 | EP1222313A2 Genes associated with obesity and methods for using the same |
| 07/17/2002 | EP1222307A1 A pcam-1 marker protein, nucleic acid sequences encoding pcam-1 and immunoassays for detection of pcam-1 |
| 07/17/2002 | EP1222289A2 Chimeric immunogenic compositions and nucleic acids encoding them |
| 07/17/2002 | EP1222288A2 Human pif1 dna helicase and uses thereof |
| 07/17/2002 | EP1222286A2 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 07/17/2002 | EP1222285A2 Protease from lucila sericata and its use in treatment of wounds |
| 07/17/2002 | EP1222284A2 22196, a novel human aminopeptidase |
| 07/17/2002 | EP1222279A2 Growth factor polypeptides and nucleic acids encoding same |
| 07/17/2002 | EP1222278A1 Oculomedin and glaucoma |
| 07/17/2002 | EP1222277A2 Endozepine-like polypeptides and polynucleotides encoding same |
| 07/17/2002 | EP1222276A2 Polynucleotides and polypeptides encoded thereby |
| 07/17/2002 | EP1222275A2 Serum amyloid a isoform from colostrum |
| 07/17/2002 | EP1222274A2 Mage-a12 antigenic peptides and uses thereof |
| 07/17/2002 | EP1222273A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 07/17/2002 | EP1222272A2 Polypeptides and polynucleotides encoding same |
| 07/17/2002 | EP1222270A2 Proteins and polynucleotides encoded thereby |
| 07/17/2002 | EP1222268A2 Vip54 protein and related materials |
| 07/17/2002 | EP1222266A2 Pca3 messenger rna species in benign and malignant prostate tissues |
| 07/17/2002 | EP1222265A1 Novel nicotinic acetylcholine receptor subunit, its isolation and use |
| 07/17/2002 | EP1222264A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 07/17/2002 | EP1222258A2 Molecules for disease detection and treatment |
| 07/17/2002 | EP1222253A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 07/17/2002 | EP1222226A1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 07/17/2002 | EP1222212A1 Il13 mutants |
| 07/17/2002 | EP1222211A1 Pcna associated cell cycle proteins, compositions and methods of use |
| 07/17/2002 | EP1222209A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 07/17/2002 | EP1222208A1 Polypeptide derivatives of parathyroid hormone (pth) |
| 07/17/2002 | EP1222206A1 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto |
| 07/17/2002 | EP1222204A1 A DNA MOLECULE ENCODING A VARIANT $g(a) 2B?-ADRENOCEPTOR PROTEIN, AND USES THEREOF |
| 07/17/2002 | EP1222203A1 Method of altering polypeptide aggregation |
| 07/17/2002 | EP1222201A2 Peptides which stimulate the immune response and tissue regeneration |
| 07/17/2002 | EP1222199A1 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent |
| 07/17/2002 | EP1221985A1 Conveyance of anti-infective activity to wound dressings |
| 07/17/2002 | EP1221976A1 Low dose ifn-gamma for treatment of disease |
| 07/17/2002 | EP1221975A2 Polymer stabilized neuropeptides |
| 07/17/2002 | EP1221973A1 CD40 antagonist for treating psoriasis |
| 07/17/2002 | EP1221970A2 Compositions and methods for stimulating an immune response against infectious agents |
| 07/17/2002 | EP1221966A1 Method for reducing the risk of cancer |
| 07/17/2002 | EP1221965A1 Use of tgf beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa |
| 07/17/2002 | EP1221964A2 Antigenic modification of polypeptides |
| 07/17/2002 | EP1221963A1 Methods of inhibiting osteoclastogenesis |
| 07/17/2002 | EP1221962A2 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 07/17/2002 | EP1221961A1 Induction of a strong immune response to a self-tumor associated antigen |
| 07/17/2002 | EP1221958A1 Analgesic from snake venom |
| 07/17/2002 | EP1221955A2 Immunostimulatory nucleic acids |
| 07/17/2002 | EP1221943A2 Method of producing sub-micron particles of biologically active agents |
| 07/17/2002 | EP1221942A1 Biodegradable microparticles with novel erythropoietin stimulating protein |
| 07/17/2002 | EP1221937A2 Hybrid matrices and hybrid matrix mixtures |
| 07/17/2002 | EP1221908A1 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| 07/17/2002 | EP1221865A2 Food supplement for increasing lean mass and strength |
| 07/17/2002 | EP1221847A1 Methods of enhancing chemotherapy |
| 07/17/2002 | EP1169048A4 Hyaluronic acid mimics and methods related thereto |
| 07/17/2002 | EP1146891A4 Inhibiting development of microvessels within vascular walls |
| 07/17/2002 | EP1012186B1 Use of a kgf protein product(s) and a glp-2 protein product(s) for the preparation of a medicament |
| 07/17/2002 | EP1007086B1 Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection |
| 07/17/2002 | EP0977581B1 Histone containing composition to treat rheumatoid arthritis |
| 07/17/2002 | EP0969860B1 Method for preparation of a therapeutic powder through coprecipitation of insulin and absorption enhancer |
| 07/17/2002 | EP0954328A4 Laminin-5 and the formation of basement membrane structure |
| 07/17/2002 | EP0863753B1 Use of perfluoroalkyl derivatives of amino acids as metallo-beta-lactamase inhibitors |
| 07/17/2002 | EP0861089B1 Methods and compositions for the delivery of monomeric proteins |
| 07/17/2002 | EP0830374B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 07/17/2002 | EP0815450B1 Compounds and methods for the dectection of t. cruzi infection |
| 07/17/2002 | EP0804219B1 Inhibin compositions and methods of use thereof |
| 07/17/2002 | EP0684763B1 Method and apparatus for treating a body fluid |
| 07/17/2002 | EP0511306B1 Tumor killing effects of enterotoxins and related compounds |
| 07/17/2002 | CN1359421A Novel polypeptide and DNA thereof |
| 07/17/2002 | CN1359420A Novel indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals |
| 07/17/2002 | CN1359392A Coupled compound of erythropoietin with glycol |
| 07/17/2002 | CN1359391A 重组腺病毒 Recombinant adenovirus |
| 07/17/2002 | CN1359390A Factor VII a inhibitors |
| 07/17/2002 | CN1359389A Substantially crystalline form of melagatran |
| 07/17/2002 | CN1359302A Remedies for immunoogical diseases |
| 07/17/2002 | CN1359301A Prevention and treatment of amyloidogenic disease |
| 07/17/2002 | CN1359300A Uro-genital condition treatment system |
| 07/17/2002 | CN1359299A Keratinocyte growth factor-2-formulations |
| 07/17/2002 | CN1359298A Novel indications of mannan-bindie lectin (MBL) in the treatment of immanocompromised individuals |
| 07/17/2002 | CN1359297A Method for preventing tumoral growth |
| 07/17/2002 | CN1358855A Novel polypeptide-human tissue proteinase 11.77 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358854A Novel polypeptide-human protein phosphatase 9.35 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358853A Novel polypeptide-humanprotein phosphatase 9.68 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358852A Novel polypeptide-human protein phosphatase 12.76 and polynuceotide for encoding said polypeptide |